Public filings / MIRM on Yahoo Finance (opens in a new tab)
MIRM: insider buying, 13F holders, analyst moves
Mirum Pharmaceuticals, Inc.
A summary of public filings about Mirum Pharmaceuticals, Inc. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
5 of our 100 managers hold MIRM
Combined reported value $106.2M; 1 sold out since Q1 2026.
Holders among our 100 managers: 3 in Q3 2023, 5 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Baker Bros. Advisors | $52.2M | 0.26% | Unchanged |
| RA Capital | $37.3M | 0.32% | Unchanged |
| Perceptive Advisors | $13.5M | 0.21% | New |
| Polen Capital | $2.4M | 0.02% | Added |
| Deerfield Company | $706K | 0.01% | New |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.